Skip to main content

Advertisement

Fig. 2 | World Journal of Surgical Oncology

Fig. 2

From: Clinical significance and prognostic value of receptor conversion in hormone receptor positive breast cancers after neoadjuvant chemotherapy

Fig. 2

Percentage of ER and PR expression pre- and post-NAC for patients with any receptor conversion. a Percentage of ER expression pre- and post-NAC for patients with any receptor conversion. b Percentage of PR expression pre- and post-NAC for patients with any receptor conversion. (ER estrogen receptor, PR progesterone, NAC neoadjuvant chemotherapy)

Back to article page